Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The dopamine hypothesis of bipolar affective disorder: the state of the art and implications for treatment
Hulegar A. Abhishekh, Tiago Reis Marques, Sameer Jauhar, et al.
Molecular Psychiatry (2017) Vol. 22, Iss. 5, pp. 666-679
Open Access | Times Cited: 431

Showing 1-25 of 431 citing articles:

Epidemiology and risk factors for bipolar disorder
Tobias Rowland, Steven Marwaha
Therapeutic Advances in Psychopharmacology (2018) Vol. 8, Iss. 9, pp. 251-269
Open Access | Times Cited: 429
A systematic review of gut microbiota composition in observational studies of major depressive disorder, bipolar disorder and schizophrenia
Amelia J. McGuinness, Jessica A. Davis, Samantha L. Dawson, et al.
Molecular Psychiatry (2022) Vol. 27, Iss. 4, pp. 1920-1935
Open Access | Times Cited: 322
Antipsychotics: Mechanisms underlying clinical response and side-effects and novel treatment approaches based on pathophysiology
Stephen Kaar, Sridhar Natesan, Robert A. McCutcheon, et al.
Neuropharmacology (2019) Vol. 172, pp. 107704-107704
Closed Access | Times Cited: 285
Neuroinflammation in Bipolar Depression
Francesco Benedetti, Veronica Aggio, Maria Luisa Pratesi, et al.
Frontiers in Psychiatry (2020) Vol. 11
Open Access | Times Cited: 241
Opposite effects of dopamine and serotonin on resting-state networks: review and implications for psychiatric disorders
Benedetta Conio, Matteo Martino, Paola Magioncalda, et al.
Molecular Psychiatry (2019) Vol. 25, Iss. 1, pp. 82-93
Closed Access | Times Cited: 218
A Test of the Transdiagnostic Dopamine Hypothesis of Psychosis Using Positron Emission Tomographic Imaging in Bipolar Affective Disorder and Schizophrenia
Sameer Jauhar, Matthew M. Nour, Mattia Veronese, et al.
JAMA Psychiatry (2017) Vol. 74, Iss. 12, pp. 1206-1206
Open Access | Times Cited: 213
The Emerging Neurobiology of Bipolar Disorder
Paul J. Harrison, John Geddes, Elizabeth M. Tunbridge
Trends in Neurosciences (2017) Vol. 41, Iss. 1, pp. 18-30
Open Access | Times Cited: 186
Circadian Rhythm Disturbances in Mood Disorders: Insights into the Role of the Suprachiasmatic Nucleus
Chelsea A. Vadnie, Colleen A. McClung
Neural Plasticity (2017) Vol. 2017, pp. 1-28
Open Access | Times Cited: 179
Understanding the nature of psychiatric comorbidity in migraine: a systematic review focused on interactions and treatment implications
Thomas Dresler, Salvatore Caratozzolo, Kaat Guldolf, et al.
The Journal of Headache and Pain (2019) Vol. 20, Iss. 1
Open Access | Times Cited: 179
Dopamine, Immunity, and Disease
Breana Channer, Stephanie Matt, Emily Nickoloff-Bybel, et al.
Pharmacological Reviews (2022) Vol. 75, Iss. 1, pp. 62-158
Open Access | Times Cited: 156
New Drug Treatments for Schizophrenia: A Review of Approaches to Target Circuit Dysfunction
Oliver Howes, Eleanor Dawkins, Maria Lobo, et al.
Biological Psychiatry (2024) Vol. 96, Iss. 8, pp. 638-650
Open Access | Times Cited: 18
Cholinergic regulation of mood: from basic and clinical studies to emerging therapeutics
Stephanie C. Dulawa, David S. Janowsky
Molecular Psychiatry (2018) Vol. 24, Iss. 5, pp. 694-709
Open Access | Times Cited: 144
Connectomics of bipolar disorder: a critical review, and evidence for dynamic instabilities within interoceptive networks
Alistair Perry, Gloria Roberts, Philip B. Mitchell, et al.
Molecular Psychiatry (2018) Vol. 24, Iss. 9, pp. 1296-1318
Open Access | Times Cited: 128
Nilotinib Effects on Safety, Tolerability, and Biomarkers in Alzheimer's Disease
Raymond Scott Turner, Michaeline Hebron, Abigail Lawler, et al.
Annals of Neurology (2020) Vol. 88, Iss. 1, pp. 183-194
Open Access | Times Cited: 102
Heterogeneity of Striatal Dopamine Function in Schizophrenia: Meta-analysis of Variance
Stefan Brugger, Ilinca Angelescu, Anissa Abi‐Dargham, et al.
Biological Psychiatry (2019) Vol. 87, Iss. 3, pp. 215-224
Open Access | Times Cited: 96
A Reward-Based Framework of Perceived Control
Verena Ly, Kainan S. Wang, Jamil P. Bhanji, et al.
Frontiers in Neuroscience (2019) Vol. 13
Open Access | Times Cited: 88
Pathophysiological Bases of Comorbidity in Migraine
Claudia Altamura, Ilenia Corbelli, Marina de Tommaso, et al.
Frontiers in Human Neuroscience (2021) Vol. 15
Open Access | Times Cited: 77
Bipolar disorder: An evolutionary psychoneuroimmunological approach
Markus J. Rantala, Severi Luoto, Javier I. Borráz-León, et al.
Neuroscience & Biobehavioral Reviews (2021) Vol. 122, pp. 28-37
Closed Access | Times Cited: 76
Neurobiological and behavioral mechanisms of circadian rhythm disruption in bipolar disorder: A critical multi‐disciplinary literature review and agenda for future research from the ISBD task force on chronobiology
Michael J. McCarthy, John F. Gottlieb, Robert Gonzalez, et al.
Bipolar Disorders (2021) Vol. 24, Iss. 3, pp. 232-263
Open Access | Times Cited: 74
The i-Motif as a Molecular Target: More Than a Complementary DNA Secondary Structure
Susie L. Brown, Samantha Kendrick
Pharmaceuticals (2021) Vol. 14, Iss. 2, pp. 96-96
Open Access | Times Cited: 69
Phenomenology, Epidemiology and Aetiology of Postpartum Psychosis: A Review
Amy Perry, Katherine Gordon‐Smith, Lisa Jones, et al.
Brain Sciences (2021) Vol. 11, Iss. 1, pp. 47-47
Open Access | Times Cited: 59
Depression in Sub-Saharan Africa
Ismail Temitayo Gbadamosi, Isaac Tabiri Henneh, Oritoke M. Aluko, et al.
IBRO Neuroscience Reports (2022) Vol. 12, pp. 309-322
Open Access | Times Cited: 52
The efficacy of cariprazine on cognition: a post hoc analysis from phase II/III clinical trials in bipolar mania, bipolar depression, and schizophrenia
Roger S. McIntyre, David G. Daniel, Eduard Vieta, et al.
CNS Spectrums (2022) Vol. 28, Iss. 3, pp. 319-330
Open Access | Times Cited: 45
Schizophrenia, Bipolar and Major Depressive Disorders: Overview of Clinical Features, Neurotransmitter Alterations, Pharmacological Interventions, and Impact of Oxidative Stress in the Disease Process
Pravat K. Mandal, Shradha Gaur, Rimil Guha Roy, et al.
ACS Chemical Neuroscience (2022) Vol. 13, Iss. 19, pp. 2784-2802
Closed Access | Times Cited: 45
Multiscale neural gradients reflect transdiagnostic effects of major psychiatric conditions on cortical morphology
Bo‐yong Park, Valeria Kebets, Sara Larivière, et al.
Communications Biology (2022) Vol. 5, Iss. 1
Open Access | Times Cited: 41
Page 1 - Next Page

Scroll to top